RVLP Annual EBITDA
-$48.23 M
+$22.11 M+31.44%
31 December 2022
Summary:
As of February 5, 2025, RVLP annual earnings before interest, taxes, depreciation & amortization is -$48.23 million, with the most recent change of +$22.11 million (+31.44%) on December 31, 2022. During the last 3 years, it has risen by +$174.57 million (+78.35%).RVLP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVLP Quarterly EBITDA
-$20.75 M
-$16.66 M-407.86%
30 June 2023
Summary:
As of February 5, 2025, RVLP quarterly earnings before interest, taxes, depreciation & amortization is -$20.75 million, with the most recent change of -$16.66 million (-407.86%) on June 30, 2023. Over the past year, it has dropped by -$9.99 million (-92.85%).RVLP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVLP TTM EBITDA
-$56.79 M
-$9.99 M-21.35%
30 June 2023
Summary:
As of February 5, 2025, RVLP TTM earnings before interest, taxes, depreciation & amortization is -$56.79 million, with the most recent change of -$9.99 million (-21.35%) on June 30, 2023. Over the past year, it has increased by +$1.29 million (+2.22%).RVLP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVLP EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.4% | -92.8% | +2.2% |
| 3 y3 years | +78.3% | -18.9% | +57.6% |
| 5 y5 years | -375.6% | -162.1% | +74.5% |
RVLP EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +481.4% | -162.1% | -177.3% |
RVL Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$20.75 M(+407.9%) | -$56.79 M(+21.4%) |
| Mar 2023 | - | -$4.09 M(-70.2%) | -$46.80 M(-1.5%) |
| Dec 2022 | -$48.23 M(-31.4%) | -$13.73 M(-24.6%) | -$47.49 M(-7.2%) |
| Sept 2022 | - | -$18.22 M(+69.3%) | -$51.16 M(-11.9%) |
| June 2022 | - | -$10.76 M(+125.2%) | -$58.07 M(-10.3%) |
| Mar 2022 | - | -$4.78 M(-72.5%) | -$64.77 M(-6.5%) |
| Dec 2021 | -$70.34 M(+1.0%) | -$17.40 M(-30.8%) | -$69.26 M(-30.3%) |
| Sept 2021 | - | -$25.13 M(+44.0%) | -$99.41 M(+75.6%) |
| June 2021 | - | -$17.45 M(+88.3%) | -$56.62 M(+0.0%) |
| Mar 2021 | - | -$9.27 M(-80.5%) | -$56.61 M(+42.1%) |
| Dec 2020 | -$69.67 M | -$47.56 M(-369.3%) | -$39.84 M(+388.5%) |
| Sept 2020 | - | $17.66 M(-201.2%) | -$8.15 M(-93.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | -$17.45 M(-332.5%) | -$134.03 M(-41.8%) |
| Mar 2020 | - | $7.50 M(-147.3%) | -$230.34 M(+3.4%) |
| Dec 2019 | -$222.80 M(+1266.8%) | -$15.87 M(-85.3%) | -$222.79 M(-24.3%) |
| Sept 2019 | - | -$108.21 M(-4.9%) | -$294.37 M(+75.4%) |
| June 2019 | - | -$113.77 M(-855.8%) | -$167.87 M(+710.9%) |
| Mar 2019 | - | $15.05 M(-117.2%) | -$20.70 M(+27.0%) |
| Dec 2018 | -$16.30 M(+60.8%) | -$87.45 M(-578.1%) | -$16.30 M(-122.2%) |
| Sept 2018 | - | $18.29 M(-45.2%) | $73.46 M(+53.3%) |
| June 2018 | - | $33.40 M(+71.7%) | $47.92 M(+230.0%) |
| Mar 2018 | - | $19.45 M(+739.0%) | $14.52 M(-394.5%) |
| Dec 2017 | -$10.14 M(+22.2%) | $2.32 M(-132.0%) | -$4.93 M(-32.0%) |
| Sept 2017 | - | -$7.25 M | -$7.25 M |
| Dec 2016 | -$8.29 M | - | - |
FAQ
- What is RVL Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals annual EBITDA year-on-year change?
- What is RVL Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals quarterly EBITDA year-on-year change?
- What is RVL Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals TTM EBITDA year-on-year change?
What is RVL Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of RVLP is -$48.23 M
What is the all time high annual EBITDA for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$8.29 M
What is RVL Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, RVLP annual earnings before interest, taxes, depreciation & amortization has changed by +$22.11 M (+31.44%)
What is RVL Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of RVLP is -$20.75 M
What is the all time high quarterly EBITDA for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is $33.40 M
What is RVL Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, RVLP quarterly earnings before interest, taxes, depreciation & amortization has changed by -$9.99 M (-92.85%)
What is RVL Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of RVLP is -$56.79 M
What is the all time high TTM EBITDA for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is $73.46 M
What is RVL Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, RVLP TTM earnings before interest, taxes, depreciation & amortization has changed by +$1.29 M (+2.22%)